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ABSTRACT
Abundant evidence from the medical, veterinary, 
and animal science literature demonstrates that there 
is substantial room for improvement of the clarity, 
completeness, and accuracy of reporting of interven-
tion studies. More rigorous reporting guidelines are 
needed to improve the quality of data available for use 
in comparisons of outcomes (or meta-analyses) of mul-
tiple studies. Because of the diversity of factors that 
affect reproduction and the complexity of interactions 
between these, a systematic approach is required to de-
sign, conduct, and analyze basic and applied studies of 
dairy cattle reproduction. Greater consistency, clarity, 
completeness, and correctness of design and reporting 
will improve the value of each report and allow for 
greater depth of evaluation in meta-analyses. Each of 
these benefits will improve understanding and applica-
tion of current knowledge and better identify questions 
that require additional modeling or primary research. 
The proposed guidelines and checklist will aid in the 
design, conduct, analysis, and reporting of intervention 
studies. We propose an adaptation of the REFLECT 
(Reporting Guidelines for Randomized Controlled 
Trials for Livestock and Food Safety) statement to 
provide guidelines and a checklist specific to reporting 
intervention studies in dairy cattle reproduction. Fur-
thermore, we provide recommendations that will assist 
investigators to produce studies with greater internal 
and external validity that can more often be included 
in systematic reviews and global meta-analyses. Such 
studies will also assist the development of models to 
describe the physiology of reproduction.
Key words: reporting guidelines, reproduction, study 
design, meta-analysis, metabolic disease definition
INTRODUCTION
Our goal is to improve the completeness, clarity, 
and correctness of design, analysis, reporting, and in-
terpretation of studies on reproduction in dairy cattle. 
This process will improve interpretation of individual 
studies. More consistent and better study design and 
reporting will maximize the ability of researchers to 
use studies of reproduction in dairy cattle in systematic 
reviews and meta-analyses and improve understanding 
of the causes of variability in results from apparently 
similar studies.
These recommendations are directed to animal and 
veterinary scientists interested in improving reproduc-
tive efficiency of dairy cattle, who would use the check-
lists and guidelines when designing studies and prepar-
ing reports for publication. The audience includes new 
and established investigators, as well as reviewers and 
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editors, who could use the guidelines to assess further 
the suitability of a paper for publication. We advocate 
that journals formally adopt the presented reporting 
checklist as part of the submission and review process 
for papers on dairy cattle reproduction.
Suboptimal reproductive performance of dairy cattle 
has been well documented in economic and produc-
tion system efficiency terms (Lucy, 2001; Norman et 
al., 2009). Reproductive performance is influenced by 
many factors, including genetics, young stock rearing, 
nutritional management, cow housing and comfort, 
management of the transition period, season, weather, 
and disease. For good reason, many of these factors 
have been studied in isolation, with little accounting for 
interacting or confounding variables, but that is chang-
ing. Research is increasingly assessing relationships for 
interaction and accounting for confounding of these 
varying effects on reproduction. Meta-analyses of nu-
tritional effects on reproduction have been conducted 
(Lean et al., 2012; Rodney et al., 2015), identifying a 
negative effect of soluble protein and positive effects 
of fatty acids on reproductive performance in lactat-
ing dairy cows, respectively. Several systems models of 
reproduction and the integration of genetics, nutrition, 
and reproduction have been recently published (Boer et 
al., 2011; Martin et al., 2012; McNamara and Shields, 
2013).
The low estimates of heritability of reproductive 
performance reflect the fact that fertility traits are 
complex and multifactorial; however, the estimated ge-
netic merit for reproductive traits is increasing (Berry 
et al., 2014). Important explanatory environmental 
variables; that is, nongenetic effects that influence 
reproduction, are unmeasured in most genetic analy-
ses and most physiology and nutrition experiments. 
Numerous environmental variables likely contribute 
considerably more compared with genetics to reproduc-
tive phenotype directly (Bello et al., 2012). The envi-
ronmental effects that need to be accounted for might 
be poorly and inconsistently measured, and definitions 
of fertility measures can vary. Such problems lead to 
the possibility of substantial unmeasured genotype by 
environment interactions. The compilation of studies 
for further detailed analyses by systematic review or 
meta-analysis may help to identify the presence and 
sources of heterogeneity of results among investigations 
of a similar research question (Bisinotto et al., 2015), 
but only if the primary studies are sufficiently valid, 
completely reported, and consistent in definitions and 
conduct to be included; unfortunately, this is rarely the 
case (Haimerl et al., 2013; Rodney et al., 2015).
Relatively few recent publications have addressed 
study design in cattle research using randomized con-
trolled trials, but examples include St-Pierre (2007) 
and Tempelman (2009). Those authors stressed the 
need for adequacy of sample size and the need to avoid 
pseudo-replication, and they discussed appropriate ap-
proaches to study design. In conducting meta-analyses 
on reproductive studies examining hormonal and di-
etary interventions, the following failings were noted 
in many of the studies evaluated: randomization or 
allocation methods were not described; the blinding of 
researchers to treatment allocation was not stated; the 
use of placebo treatments was not stated; some studies 
lacked clarity in regard to whether nutritional treat-
ments were allocated to individual cattle or groups of 
cattle; and relatively few papers provided or correctly 
analyzed time-to-event outcomes; for example, time to 
first service or pregnancy (Amann, 2005; Haimerl et al., 
2013; de Boer et al., 2014; Rodney et al., 2015). Finally, 
notwithstanding earlier attempts to standardize report-
ing of reproductive outcomes (Fetrow et al., 1990), there 
has been inconsistent use of outcome measures and ter-
minology in studies of reproductive performance. These 
failings are not unique to reproductive studies; others 
have documented deficiencies in study design and re-
porting in human and veterinary medicine (DerSimo-
nian et al., 1982; Elbers and Schukken, 1995; Moher et 
al., 2001; O’Connor, 2010). Further, the problems of 
reproductive research study design are not isolated to 
cattle (Kastelic and Gandolfi, 2005). Substantial flaws 
in reproductive study design for studies involving horses, 
cattle, swine, companion, laboratory, and wild animals 
have been noted (Amann, 2005; Simoneit et al., 2011). 
The need to use research resources efficiently and to 
maximize the information gleaned from experiments on 
reproductive performance of dairy cattle provided the 
major stimulus to develop these guidelines. Reporting 
guidelines are one useful tool to improve the quality of 
published research (O’Connor, 2010). The “CONSORT 
statement,” checklist and explanation document (Con-
solidated Standards of Reporting Trials; Moher et al., 
2001) was developed primarily for human medicine to 
provide guidelines for design, conduct, and reporting 
of randomized controlled trials and contain standard 
methods and guidelines for reporting measures. Vet-
erinary medical and food safety specialists adapted 
CONSORT to produce the “REFLECT statement” on 
Reporting Guidelines for Randomized Controlled Tri-
als (O’Connor et al., 2010; Sargeant et al., 2010) for 
livestock trials, and guidelines for animal research have 
also been produced (Kilkenny et al., 2010). Papers in 
medical journals that endorse the CONSORT guidelines 
have more complete reporting of randomized controlled 
trials, although after many years, there is still room for 
improvement (Turner et al., 2012).
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A CHECKLIST AND GUIDELINES FOR STUDIES  
IN DAIRY CATTLE REPRODUCTION
Awareness of the limitations in the capacity of any 
individual research group to address the challenges of 
improving reproductive performance of cattle grew 
among researchers in the fields of reproduction, nutri-
tion, genetics, and disease. Additionally, evaluations of 
study designs and reporting in reproductive research 
encountered in the process of research syntheses (e.g., 
Boer et al., 2011) stimulated discussion among research-
ers on an informal basis. The need to improve reproduc-
tive study design and reporting became clear. Meetings 
were organized in 2011, 2012, and 2013 in conjunction 
with the American Dairy Science Association®–Ameri-
can Society of Animal Science annual meetings, and 
an ad hoc subgroup of participants undertook to de-
velop recommendations on the conduct and analyses 
of reproductive intervention studies, using a process 
of discussion and iterative evaluation of information, 
based on the principles and documents developed in 
the REFLECT (O’Connor et al., 2010; Sargeant et al., 
2010) and CONSORT statements (Altman et al., 2001, 
2012). The rationale for the development of specific 
guidelines was that there were sufficient matters of im-
portance and uniqueness to warrant separate guidelines 
and discussion for reproductive intervention studies 
using dairy cattle.
We adapted the REFLECT checklist to apply to 
dairy cattle reproduction intervention studies. Table 
1 provides a checklist and brief rationale for the best 
practices of study design. Table 2 describes in more 
detail our suggested definitions and correct statistical 
analyses of reproductive performance outcome mea-
sures. Table 2 is supported by Supplemental Table 
S1 (http://dx.doi.org/10.3168/jds.2015-9445), which 
provides detail of less commonly used reproductive 
measures. It is important to describe environmental 
conditions. Consequently, suggestions to provide con-
sistent measures and methods to describe environment 
and nutrition are provided in some detail. Supplemen-
tal Table S2 (http://dx.doi.org/10.3168/jds.2015-9445) 
summarizes standardized animal, environmental, and 
nutritional variables for study design and reporting. It 
is clearly not our intent that studies should report all 
of these items; instead, this compilation is intended to 
encourage inclusion of as much as is feasible of this 
contextual information by standardized inclusion of 
these covariates. Any given study would certainly not 
manipulate or even be able to control for all these fac-
tors, but as complete a description and definition of 
the circumstances of the study as possible will improve 
interpretation and utility of the study. We acknowledge 
that funding or logistical constraints will limit the size 
and scope of studies and the covariates that can be 
measured, and that smaller-scale preliminary studies 
are often needed to begin to generate data to address a 
research question. However, all studies will make their 
best contribution when the points in Table 1 are con-
sidered in study design and comprehensively reported. 
Table 2 provides guidelines for definitions of disease. 
Consistent use of clear, validated terminology, case 
definitions, and diagnostic criteria will help researchers 
understand the effects and interactions of disease on 
reproduction.
The remainder of the paper describes elements of the 
reporting guidelines in more detail.
ELABORATION OF THE CHECKLIST
Hypotheses and Objectives (Table 1, Item 5)
The statement of concise hypotheses must be includ-
ed with an explicit statement of the objectives of the 
study; primary objectives must be clearly distinguished 
from secondary objectives. The hypothesis is a critical 
attribute of any study, and failure to state a hypothesis 
is a critical failure. It is common in reproductive studies 
to examine multiple outcomes. Primary outcomes are 
the outcomes of greatest interest; these variables should 
determine the study sample size. Other outcomes are, 
by definition, less important and should not determine 
the sample size. Investigators should be aware of the 
potential to increase risk of type I statistical error by 
multiple hypothesis testing without adequate adjust-
ment and should aim to limit the hypotheses tested to 
those that are consistent with the stated objectives of 
the study.
Example:  
“Therefore, the aim of this study was to charac-
terize the phenotypic performance of cows with 
similar genetic merit for milk production traits 
and similar proportions of Holstein genes, but 
divergent genetic merit for fertility traits (geno-
types Fert+ and Fert−). Specifically, we tested 
the hypothesis that cows with negative estimated 
breeding value (EBV) for calving interval would 
have superior fertility performance, would be less 
reliant on body reserve mobilization, and would 
have detectable differences in circulating concen-
trations of metabolic hormones and metabolites 
compared with cows that had positive EBV for 
calving interval (Cummins et al., 2012).”
It is important to consider the appropriate type of 
hypothesis and the effects on interpretation of the 
study and sample size. Four possible types of statistical 
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Table 1. Checklist and brief rationale for design, conduct and reporting of research experiments in dairy cattle reproduction, adapted from the 
REFLECT guidelines (Sargeant et al., 2010)
Item  
no.  
REFLECT paper  
section  Reproduction reporting guideline and importance to study quality
 Checklist: 
Reported on  
page ___ of  
the paper
1 Title and abstract The design of the study is explicitly stated (e.g., randomized controlled trial) in the 
title and abstract.
 
2 Introduction— 
Background
The introduction clearly and concisely explains the problem or question that the 
study will address, and cites key literature that, if relevant, supports or contradicts 
the hypothesis of the study.
 
3 Methods— Participants Inclusion and exclusion criteria are stated explicitly. 
The experimental unit is described clearly [e.g., the cow (with or without repeated 
measures), estrus cycle, insemination, single or multiple rounds of synchronization, or 
herd]. Genetic identity is ideally characterized. Critical to study quality.
 
4 Interventions (a) Precise details of the interventions intended and how, when, and at what level (herd, 
cow, estrus cycle or insemination) treatments were actually administered for each 
group are reported. Critical to study quality.
 
Interventions (b) Details of interventions in each group are described, including the nature of the 
control (placebo or no treatment, or basal treatment or positive control). Important 
to study quality.
 
5 Objectives A concise hypothesis statement is included. 
The objectives are clearly stated and distinguished as primary (i.e., that drive the 
design) or secondary. Critical to study quality.
 
6 Outcomes The primary (i.e., that drive the sample size) and secondary outcomes are explicitly 
stated. The follow-up or observation period is stated (e.g., for how long after 
intervention cows were monitored or eligible to be recorded). The handling of 
data from cattle that did not experience the outcome of interest (e.g., were not 
inseminated or did not become pregnant during the observation period) is explicitly 
stated. Causes of censoring are reported. 
The use or eligibility for, methods and intensity of estrus detection are described. 
Important to study quality. 
The method and timing (days after insemination or end of mating) of pregnancy 
diagnosis are described. The criteria used for pregnancy (e.g., membrane slip by 
palpation; visualization of fluid, embryo or heartbeat by ultrasound; the cut-point 
used for chemical tests) are described. If a chemical test for pregnancy is used, a 
reference to validation data for the test is provided.
 
7 Sample size The basis of the sample size (for each outcome, if relevant) is clearly stated, including 
the nature of the outcome variable [binary; categorical; continuous; comparison of 
proportions, means, counts, or time-to-event), the expected outcome or difference, the 
expected variance, and the chosen confidence (α) and power (β)]. Nonindependence 
(clustering; e.g., correlation of inseminations within a cow, or cows within a herd) 
is accounted for. If there are multiple levels (e.g., insemination, cow, or herd) of 
outcomes or covariates, that is accounted for. Critical to study quality.
 
8 Randomization–Sequence 
generation
The level (farm, breeding period, cow, insemination) at which treatments are applied 
is stated and is congruent with the stated objectives and with the unit of statistical 
analysis. Critical to study quality. 
Descriptive data, including a measure of variance, is provided to demonstrate the 
success of matching and/or of random assignment to treatment across important 
covariates (e.g., if cows were matched on previous lactation milk yield, the mean and 
SD yields; similarly (as appropriate) covariates (e.g., parity, DIM at treatment, BCS, 
inseminator, fertility index of bulls used) are shown to be similar (balanced) between 
treatment groups.
 
9 Randomization— 
Allocation concealment
The method used to generate and apply random treatment assignments is described. 
The method of allocation of experimental units to treatment is described, including 
who assigned and applied treatments and whether the same personnel were involved 
in making observations. Use of random treatment assignment is explicitly stated in 
the abstract and in the methods. Critical to study quality.
 
10 Randomization— 
Implementation
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Table 1 (Continued). Checklist and brief rationale for design, conduct and reporting of research experiments in dairy cattle reproduction, 
adapted from the REFLECT guidelines (Sargeant et al., 2010)
Item  
no.  
REFLECT paper  
section  Reproduction reporting guideline and importance to study quality
 Checklist: 
Reported on  
page ___ of  
the paper
11 Blinding (masking) Blinding (hiding of treatment assignments to personnel and assessors) is described at 
the levels of allocation to treatment, care and management of animals, observation 
of outcomes and covariates, and statistical analysis. Blinding should be as complete 
as possible; for example, caregivers or assessors should not be aware that cattle or 
pens are treatment A or B, even if they do not know what each represents. If blinding 
is not done or not complete, justification is provided. Inherent to this will be use of 
“sham” (placebo) treatments for control cattle. Important to study quality.
 
12 Statistical methods The statistical methods are explicitly linked to the objectives and the experimental 
unit.
 
The statistical methods are correct for the nature of the data (see Table 2). Critical 
to study quality. 
Adjusted analyses and the covariates included in mathematical models and adjusted 
results (e.g., least squares means) are described.
Testing of model assumptions (e.g., normality; linearity of continuous predictors) and 
of assessment of fit of models are described.
When outcomes are not independent due to possible clustering (e.g., cows with a herd 
in a multi-herd study or repeated measures), these effects are explicitly addressed in 
the analysis. The use of fixed, random or mixed effects in the study for herds, pens, 
animals, and time (for repeated measures) should be explicitly stated and justified.
P-values are quantified to <0.001 (i.e., P = 0.71 or P = 0.003, not “P < 0.05” or 
“NS”). It is preferable to report 95% confidence intervals or equivalents around 
measures of effect.
Critical to study quality.
13 Results–Study flow The numbers of animals examined, enrolled/treated, excluded, withdrawn, lost to 
follow-up or having missing or unusable data, and analyzed are provided for each 
group, normally in a diagram or table.
 
14 Recruitment The geographic location of the study site(s), dates of the study, housing/management 
system, and general environmental conditions are described.
 
 
15 Baseline data Where relevant or feasible, the diets fed are described (see Supplemental Table S2; 
10.3168/jds.2015-9445). If intake is not directly measured, estimation of a surrogate 
descriptor of intake (e.g., pen-level feed delivery and refusals) is desirable.
Descriptive data (n, mean, median, or proportion, and a measure of variance) are 
provided for each treatment group on breed, age or parity, stage of lactation, body 
condition, milk production.
16 Numbers analyzed For each result presented, the number of observations in the analysis, the effect 
estimate, and a measure of its variance (SD, SE, or confidence interval) is presented. 
Critical to study quality.
 
17 Outcomes and estimation  
The numbers included in the analysis are described as being based on intention 
to treat or on final inclusion criteria. Specifically, the number and proportion of 
animals initially recruited or enrolled but not included in each final analysis is stated 
explicitly.
The covariates in multivariable models are listed, or their effects are presented as 
for main effects. When relative measures of effect (e.g., odds ratio, relative risk, or 
hazard ratio) are presented, a description of absolute performance and its variance 
is also included (e.g., proportion of animals inseminated in a specified period; 
probability of pregnancy per insemination; median days to pregnancy). Critical to 
study quality.
18 Ancillary analyses If multiple comparisons of treatment are made on the same data, adjustments of 
methods or interpretation are described. If analysis of a subgroup is performed, the 
justification for it is clearly stated (e.g., based on an a priori hypothesis, which should 
be reflected in the study design, or detection of an interaction).
 
19 Adverse events The number of animals withdrawn for protocol violations, welfare reasons, disease, 
or death is reported for each group. It is critical, in intervention studies, to note and 
report any adverse reaction as these can be related to treatment. Pharmaco-vigilance 
is an important role of research. Important to study quality.
 
Adverse or side effects reasonably attributable to treatment are reported or the 
absence of these is stated.
Continued
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null hypotheses can be tested: no difference, inferiority, 
superiority, and nonequivalence (i.e., either superior or 
inferior). No difference is the most commonly tested 
null hypothesis, but some studies test the inferiority, 
nonequivalence (Donner 1984), or, rarely, superiority, 
of one treatment relative to another. A noninferiority 
alternative hypothesis is often used for evaluating the 
efficacy of an experimental treatment against a positive 
control when it is hypothesized that the experimen-
tal treatment is clinically not inferior in effectiveness 
(D’Agostino et al., 2003; Piaggio et al., 2012) and may 
be quicker, cheaper, or simpler.
Participants and Study Unit (Table 1, Item 3)
Authors should accurately and completely describe 
cattle with the taxonomic identifier, breed(s), sex(es), 
age(s), and productive status(es). Enhanced definitions 
of identity may be useful for literature searching using 
computer algorithms because, for example, a computer 
search may not recognize that a cow and a heifer both 
refer to Bos taurus. With increasing availability of infor-
mation on single nucleotide polymorphisms, it may be 
prudent to retain samples of hair (including follicles) or 
other biological material suitable for subsequent geno-
typing. Authors should provide gene accession numbers 
for all genes referenced in the paper, according to the 
National Center for Biotechnology Information’s Gene 
database (http://www.ncbi.nlm.nih.gov/gene).
Authors must clearly state the experimental unit 
and the unit of statistical analysis. The unit of analy-
sis may be the insemination, the 21-d breeding period 
(when analyzing 21-d estrus detection and 21-d preg-
nancy risks, for example), the lactation, or the cow (see 
Supplemental Table S1; http://dx.doi.org/10.3168/
jds.2015-9445). Units can also be aggregated to the 
group within herd or to the herd level. The experimen-
tal unit can often differ from the unit of analysis. For 
example, the experimental unit may be a pen but the 
unit of analysis may be a cow. In intervention trials, the 
experimental unit can be defined as the smallest sys-
tem or unit of experimental material to which a single 
treatment (or treatment combination) is assigned by 
the investigator (Hurlbert, 1984). Treatments should 
be applied and replicated such that the treatment ap-
plied to one experimental unit cannot affect another 
experimental unit. For reproductive studies in which 
group interactions are important (e.g., sexually active 
groups may influence the sensitivity of detection of 
estrus of other cattle), investigators should think care-
fully about study designs that account for these effects. 
Pseudo-replication can occur where there is a failure 
to distinguish between the experimental unit and the 
units of analysis within an experimental unit (Hurlbert, 
1984; St-Pierre, 2007).
Treatments (Table 1, Item 4)
Provide specific details of interventions (treatments) 
used. Terms such as “applied per labeled instructions,” 
“as per manufacturer’s instructions,” “standard indus-
try practices,” or “routine treatment” do not provide 
sufficient detail to ensure they are able to be repeated 
in subsequent studies (Sargeant et al., 2010) and must 
be avoided. In particular, for studies that involve syn-
chronization of estrus or ovulation, the allocation and 
Item  
no.  
REFLECT paper  
section  Reproduction reporting guideline and importance to study quality
 Checklist: 
Reported on  
page ___ of  
the paper
20 Discussion—
interpretation
The study’s novelty, strengths/benefits, limitations, weaknesses, or harms are 
explicitly described and discussed. Effects of treatment or of the study beyond the 
intended unit of study are considered; for example, the implications of hormonal 
treatments that produce sexually active groups should be considered when treated 
cattle are mixed with controls.
 
The discussion is objective and reflective.
21 Generalizability Discussion includes the contexts or management systems in which the results are 
likely applicable, or to which the results should not be extrapolated.
 
22 Overall evidence  
23 Analytical methods1 Validation of all laboratory methods and assays in cattle is supported with data 
or references. The limits of quantification and intra- and interassay coefficients of 
variation are reported. Critical to study quality.
 
24 Conflict of interest1 The sources of funding for the study are listed. Conflicts of interest for authors are 
disclosed.
 
1Not included in the REFLECT guidelines (Sargeant et al., 2010).
Table 1 (Continued). Checklist and brief rationale for design, conduct and reporting of research experiments in dairy cattle reproduction, 
adapted from the REFLECT guidelines (Sargeant et al., 2010)
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Table 2. Suggested measures to be used in reproductive studies—units of analysis, inclusion criteria, definitions, and statistical methods
Measure  
Unit of  
analysis  Inclusion criteria  Event to be defined  
Analyses should  
account for1  Statistical method
Interval from calving to an event:          
 To first ovulation Cow2 All cows First ovulation date Clustering of data Survival analysis with right 
censoring of cows not yet ovulated 
when observations ceased
 To first observed estrus Cow2 All cows First observed estrus date Clustering of data Survival analysis with right 
censoring of cows not yet observed 
in estrus when observations ceased
Interval from either calving 
 or start of breeding  
 period date to an event:
         
 To first insemination Cow2 All cows still in group on their start 
of breeding period date and eligible 
for insemination; exclude cows 
inseminated during their voluntary 
waiting period (VWP)
First insemination date Clustering of data; 
VWP duration
Survival analysis with right 
censoring of cows not yet 
inseminated when inseminations 
ceased
 To pregnancy Cow2 All cows still in group on their start 
of breeding period date and eligible 
for insemination; exclude cows 
inseminated during their VWP
Pregnancy date Clustering of data; 
VWP duration
Survival analysis with right 
censoring of cows that did not 
become pregnant. For the latter, 
the interval ends when the cow left 
the study (died, sold, completed 
the experiment, became ineligible 
for breeding)
Binary outcome variables3          
 Pregnancy to first insemination Cow2 Only inseminated cows that were 
pregnancy tested long enough after 
first insemination to detect any 
resulting pregnancy
Pregnancy date Clustering of 
data; calving to 
first insemination 
interval
Logistic or Poisson regression
 Pregnant at the end of mating period Cow2 All cows in group and eligible for 
insemination from their start of 
breeding period date until the first 
Pregnancy date or end of mating date 
plus time to pregnancy test; exclude 
cows inseminated during their VWP
Pregnancy date Clustering of data; 
VWP duration; 
duration of 
breeding period
Logistic or Poisson regression
 Pregnant at the end of the study Cow2 All cows in group and eligible for 
insemination from their start of 
breeding period date until the first 
Pregnancy date or end of study date 
plus time to pregnancy test; exclude 
cows inseminated during their VWP
Pregnancy date: 
(lengths of time from start 
of breeding period dates to 
last pregnancy diagnosis 
should be described.)
Clustering of data; 
VWP duration; 
duration of 
breeding period
 Logistic or Poisson regression
 Pregnancy loss Cow2 Only cows that were diagnosed as 
pregnant and subsequently monitored 
for pregnancy loss. The method by 
which pregnancy was first diagnosed 
and by what day post insemination; 
and the days after confirmation 
of pregnancy was pregnancy loss 
diagnosed should be provided.
Pregnancy loss Clustering of data. 
If binary variable 
(i.e., loss, yes or 
no), times in which 
pregnant cows 
were observed for 
pregnancy loss
If binary variable (loss = yes or 
no), logistic or Poisson regression. 
If time from confirmed pregnancy 
to assumed date of pregnancy loss, 
use survival analysis with right 
censoring of pregnant cows that 
did not lose their pregnancy at 
last time that any loss would have 
been detected.
1Adjustment required if the stated variable varies between cows; other potential confounders should also be assessed.
2Or lactation where multiple lactations from the same cow are included.
3For binary outcomes, Poisson regression to estimate risk ratio rather than the odds ratio from logistic regression is acceptable or even preferable (see Ospina et al., 2012).
 LEAN ET AL.
Journal of Dairy Science Vol. 99 No. 1, 2016
timing of treatments should detail both the intervention 
and the animals receiving it with regard to time from 
calving and parity and any other factors determining 
when treatments are administered. In many cases, a 
clear diagram that details the precise timing of inter-
ventions is useful. Details on the doses and source of 
different preparations used should also be provided. For 
pharmaceutical interventions, the minimum description 
should include the compound name, the concentration, 
the dose, the delivery matrix, and the route and the 
frequency of administration (Sargeant et al., 2010).
Particular attention is needed to describe the trial 
design and at which level (e.g., farm, pen, animal, 
or a lower level) that treatment was applied. Details 
should be provided to ensure that differences in man-
agement among treatment groups are clearly identified, 
especially details of environment, nutrition, grouping, 
and other differences among subgroups of cattle. Al-
location of semen may not be balanced across cattle 
of different production or genetic value and could be a 
source of bias. Consequently, the method of allocating 
semen should be described. Further, differences in the 
performance of inseminators are possible and the allo-
cation of inseminators across treatment groups should 
be accounted for in study design and analysis. The 
method of controlling for potential confounding effects 
of inseminators should be described. If randomization 
is conducted within subgroups, this should be clearly 
stated; for example, “heifers in each herd were random-
ized to treatment 1 or 2 within farm”; or “pens were 
allocated within each farm to treatment A or B.” It 
must be clear whether the allocation of treatment was 
made at the level of the individual or at the group. This 
is particularly important for nutritional interventions; 
ambiguity on this point is common. For example, “each 
cow was individually fed with XX g of product Y per 
day or with XX g of placebo as a top-dress for the total 
mixed ration to which only that cow had access; indi-
vidual daily feed intakes were recorded.” Full details of 
dietary interventions, ingredients and chemical compo-
sition, and placebo should be provided; approaches to 
describing rations are provided below.
Bacterial or viral challenge studies are rarely used in 
reproductive research but examples do exist (McGowan 
et al., 1993); for a detailed discussion of the use of 
these, readers are directed to Sargeant et al. (2010). 
Although not strictly challenge studies in the typical 
sense, studies of metabolic clearance (e.g., progesterone 
catabolism in circulation, or hyperinsulinemic-euglyce-
mic clamps) should preferably be conducted in animals 
that are relevant to the objective of the study; that is, 
nonlactating or ovariectomized heifers or cows may not 
be representative of dairy cows in early lactation.
Blinding (Table 1, Item 11)
There are obvious advantages in blinding assessors 
of outcomes to treatment allocation. Unlike in human 
medicine, there is no need to obscure the nature of the 
treatment from the patients themselves to avoid a psy-
chological “placebo effect,” particularly on self-reported 
outcomes; rather the focus is on those who conduct 
the study. However, “sham” treatments with placebos 
(as distinct from no treatment) may be required to 
maintain blinding to avoid differential measurement er-
ror (i.e., measurement error that varies by treatment). 
For example, if treated cows are handled or restrained, 
their feeding and social routines disrupted, or a pos-
sibly unpleasant experience imposed (e.g., receiving an 
injection), these actions should equally apply to the 
control group even if they are not strictly necessary 
to deliver “untreated” status, unless that comparison 
is the goal of the study. In a meta-analysis of human 
experiments comparing blinded and nonblinded as-
sessments of binary outcomes in patients, despite a 
generally high degree of agreement between assessors, 
Hróbjartsson et al. (2012) identified an optimistic, 
average exaggeration of the nonblinded odds ratio by 
36% relative to the blinded odds ratio. It is unlikely 
that objective outcomes such as pregnancy diagnosis 
would be influenced by conscious or unconscious biases 
if treatment allocation were known, or that animal 
identifications and treatment assignments would be 
remembered when analyzing plasma samples in a large 
study. However, outcomes such as detection of estrus 
based on secondary signs or measurement of the size 
of ovarian structures by ultrasound, or assignment of 
BCS are susceptible to differential bias if observers are 
not blinded to treatment status. It may be sufficient 
to cause bias if observers are aware that animals with 
odd-numbered ear tags or in a certain group received a 
different treatment than other animals, even if they do 
not know which treatment a particular group received.
Whereas attention to randomization is designed to 
provide the best opportunity for allocation of treat-
ments to otherwise similar groups, blinding should 
ensure that groups are treated equally. In many cases, 
placebos that look, smell, or feel like the test articles 
are required to ensure that there is blinding. In some 
cases, especially with nutritional interventions, it can 
be difficult to develop a sham treatment. If blinding is 
not used, a rationale for this decision and discussion of 
possible biases should be provided in the text.
Sargeant et al. (2010) provided a detailed outline and 
rationale for the use of blinding and suggested that 
a detailed description of how treatments were blinded 
from those involved in assessing outcomes would im-
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prove understanding of the risk of bias due to aware-
ness of treatment. Recommendations were similar to 
those in CONSORT (Altman et al., 2001). Haahr and 
Hróbjartsson (2006) reviewed 200 human experiments 
published after CONSORT (in 2001) and found that, 
of 156 articles described as “double blind,” only 2% of 
the articles explicitly described the “blinding” status 
of patients, health care providers, and data collectors. 
Haimerl et al. (2013) examined the design of studies 
used to examine prostaglandin treatment of endome-
tritis in cattle. Differences in estimates of treatment 
effects based on study design were found and, despite 
a limited study base, there was evidence of failure to 
randomize or blind studies.
Outcomes (Table 1, Items 5 and 6)
It is critical to define the case or reproductive event 
and outcomes (see Table 2 and Supplemental Table 
S1; http://dx.doi.org/10.3168/jds.2015-9445) and to 
specifically define the populations that are eligible for 
inclusion in calculations of each measure. Definitions 
of events are vital to controlling sources of variation 
in studies. Authors should clearly state the voluntary 
waiting period (VWP) applied to each experimental 
unit when insemination or pregnancy is an outcome. 
The breeding period start date should be defined as 
calving date plus voluntary waiting period + 1, where 
VWP is the postpartum period during which no insemi-
nations are allowed, even when cows are detected in 
estrus. It is acceptable to assume that this is the same 
for all cows in a group as long as it reflects the actual 
decisions about when first insemination occurs.
In all cases, the period of putative treatment effect 
should be defined. For example, an intervention may 
have a putative effect on the outcome at a single mat-
ing or throughout the breeding period. The time at 
which cows may be eligible for treatment is important. 
Statements such as “only cows less than 150 days in 
milk at the time of the first injection were enrolled” and 
“the follow-up period for determination of pregnancy 
was 60 days after the last mating, and pregnancy was 
reconfirmed at 7 months of pregnancy by rectal palpa-
tion” provide clarity.
For seasonal and split-calving herds, all or most cows 
are allocated the same calendar date for their start of 
breeding period date (also known as the herd’s mat-
ing start date or planned start of mating). Thus, the 
VWP for these cows ends 1 d before the herd’s mating 
start date. The breeding period duration for each cow is 
defined as the last date at which insemination (artificial 
or by bulls) would be allowed should estrus be detected 
− start of breeding period date + 1.
Standard operating procedures should be in place and 
described for all procedures used and previously vali-
dated systems of measurement should be referenced; for 
example, validated body condition scoring, lameness 
measures, or cut-points for chemical determinations of 
pregnancy should be used.
Sample Size and Power Calculations (Table 1, Item 7)
A power (1 − β) of 80% and type 1 error risk of 5% 
(α) are often used in calculations of sample size. For 
studies examining continuous outcomes, an estimate of 
the magnitude of the treatment effect is the effect size 
of a study, which is the difference in the experimental 
group mean minus the control group mean, divided by 
the pooled standard deviation of the two groups. Most 
reproductive studies evaluate binary outcomes (Table 
2; Supplemental Table S1; http://dx.doi.org/10.3168/
jds.2015-9445), and effect size estimates for these stud-
ies can be based on the differences between proportions 
in outcomes for the experimental and control groups. 
The effect size difference that can be detected will be 
inversely related to sample size: the smaller the differ-
ence, the larger the required group sizes. The sample 
size is also determined by the type of alternative hy-
pothesis investigated; that is, no difference, inferiority, 
superiority, and nonequivalence, and for the latter 3, 
the size of the margin used to determine the difference 
between groups. Numerous texts, papers, and software 
(Donner, 1984; Nakagawa and Cuthill, 2007; Tempel-
man, 2009; Piaggio et al., 2012) discuss and provide 
formulas concerning methods and considerations for 
power or sample size calculation, so these details will 
not be discussed further here.
For illustration, to detect an intervention effect that 
increases the probability of pregnancy at an insemina-
tion from 35 to 40% with a power (1 – β) = 0.8 and α 
= 0.05 requires 1,471 cows per group. Additional cows 
may be required to account for clustering (i.e., lack 
of statistical independence) of cows within groups and 
herds. Sample size calculations should be made consid-
ering exclusions after enrollment and losses to follow-up 
that might influence testing of the primary hypothesis; 
for example, deaths or culls during the period from 
before calving to start of the breeding period would 
reduce the number of cattle available to test differences 
among treatment groups. Although, ideally, losses are 
controlled by careful study management, large studies 
and longitudinal studies (sometimes over several years) 
will have loss of study units. It is important to de-
scribe losses of study units and the reasons for these 
losses because these may influence the validity of the 
study. It is common for 5 to 10% of cows to be culled 
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between calving and the start of the breeding period, 
and a larger proportion may experience some form of 
disease that might be an exclusion criterion. For ex-
ample, if the study excludes cattle with any clinical 
disease events before or during the study or explores 
a subgroup analysis of only cyclic or successfully syn-
chronized cattle, these results will not be applicable to 
herds as a whole.
Randomization and Blocking (Table 1, Items 8 to 11)
A statement such as “cows were randomly assigned to 
treatment” does not contain sufficient detail to ensure 
that a truly randomized assignment of study units oc-
curred. The method used to assign study units should 
be described in sufficient detail to understand how the 
random assignment occurred and how any stratification 
or blocking of subpopulations was managed. The defin-
ing principle of this process is to ensure that within 
each study stratum, cattle have an equal opportunity 
to be assigned to each group and that the treatment to 
which a specific study unit is allocated is determined by 
a chance process and cannot be predicted (Sargeant et 
al., 2010). Ad hoc allocation is not a random process; 
the study should only be called a randomized trial if a 
formal random allocation process was used. In repro-
ductive studies, there is a considerable risk if awareness 
of group allocation exists for farm workers or managers 
to manipulate the allocation of treatment, if there is a 
perceived benefit for high-producing or valuable cows.
The application of blocking should be done with cau-
tion but it can reduce the risk of having imbalanced 
groups by chance in terms of obvious confounding fac-
tors such as breed, calving date, parity or age, location, 
or production level. Blocking can be most useful when 
there is large variation between study units in strong 
determinants of reproductive performance and when 
sample sizes are small. Consideration should be given 
to previous treatments in herds in which research is 
commonly conducted because prior treatments might 
influence responses in the study in question.
A simple, explicit statement of who was responsible 
for generating the random numbers sequence, specific 
details of who managed the method of allocation of 
treatments to the study units, and how the sequence 
was concealed from participants, including staff in the 
study, will provide evidence of study rigor. Terms such 
as “blind” or “double blind” alone should be avoided, as 
these are not explicit.
Periods of Recruitment and Follow-Up  
(Table 1, Item 13)
The period over which study units were enrolled into 
a study, as well as a clear description of the duration 
of observation of covariates and outcomes, provides an 
understanding of seasonal influences and the similarity 
of exposure to environmental conditions for the cattle 
throughout a study. Marked differences may exist in 
environmental and nutritional exposures for cattle that 
calve several weeks apart. These differences should be 
reported, and it may be appropriate to control for this 
effect either by blocking or by statistical means. Further, 
extended periods of follow-up can influence reproduc-
tive studies because cows that are slow to conceive may 
have more opportunities for breeding and provide data 
that are skewed to the right in terms of time-to-event 
data or increase the numerator of an outcome such as 
services per conception. Adverse or extreme weather 
conditions may influence responses to treatment and 
should be reported. Defining the period of eligibility for 
observation of estrus or for mating is critical in repro-
ductive studies examining time to estrus or pregnancy, 
respectively.
Laboratory Analytical Methods
If assays are validated to standard analytes of inter-
est, reference to that validation is sufficient to satisfy 
this aspect of the reporting requirements. The Food 
and Drug Administration (2001) provides a sound ref-
erence that should be consulted for additional detail 
on the use of analytical methods. Analytic tests (RIA 
or ELISA) should be validated for the species and 
sample type; for example, serum, plasma, or other. If 
plasma is used, the assay should be validated for the 
particular anticoagulant in the plasma. A description 
of assay validation includes the primary and secondary 
antibodies used (species and source) and the dilution or 
concentration of the primary and secondary antibodies.
One important feature of the primary antibody is its 
specificity with respect to other closely related anti-
gens. Cross-reactivity is classically defined as the ratio 
of the concentration of the unlabeled antigen to the 
concentration of the cross-reactant at 50% displace-
ment of the standard curve and is typically less than 
1%. The species and source of the standard should be 
included in the assay validation. For RIA, a descrip-
tion of the tracer, including the method of radioactive 
labeling and specific activity (mCi/mg) of the tracer, 
should be included. The total number of disintegrations 
per minute (dpm) added to each assay tube should be 
reported. The percentage of radioactivity bound at the 
specified antibody dilution and the percent of non-
specific binding should be reported. The composition 
of assay buffers, incubation times and temperatures, 
the method for separation of bound and free, and the 
method for measuring radioactive decay (i.e., counting) 
within the bound or free fractions should be explained. 
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The stability of samples should be tested by evaluation 
of 3 samples at high, middle, and low concentrations 
through 3 freeze-thaw cycles (Food and Drug Admin-
istration, 2001). A standard curve for the assay should 
be described in terms of the mass of hormone at each 
point of the standard curve. It is important to include 
high-, middle-, and low-concentration quality control 
samples in each assay run. These should be prepared 
in triplicate based on the number of anticipated assay 
runs. The test should be designed so that the bulk of 
the assay determinations reside within the middle of 
the mass range, where the accuracy and precision of the 
test are the greatest.
The analytical sensitivity or lower limit of quantifica-
tion of the test should be reported as the minimum hor-
mone concentration or mass that can be distinguished 
from zero. Some authors use a value of average percent 
binding of the zero tube (no antigen) minus 2 SD as a 
reasonable approximation of the percent binding at the 
minimum sensitivity of the assay. One validation crite-
rion is that assaying a serial dilution of serum or plasma 
should yield a displacement curve that is parallel to the 
standard curve (often referred to as “parallelism” or 
“linearity”). An additional expectation of a valid assay 
is that adding a known amount of mass to a sample 
will yield a recovery of the added mass of 100% (often 
referred to as a test for “recovery” or “added mass”). If 
1 ng of hormone is added to a serum sample contain-
ing 1 ng, for example, then the assay result should be 
2 ng (100% recovery of added mass). For assays that 
require extraction of the antigen from serum or plasma, 
an “extraction efficiency” should be included (percent 
of antigen mass removed from the sample via the ex-
traction method). The extraction efficiency is typically 
estimated by spiking a known amount of radiolabeled 
antigen, performing the extraction, and then measur-
ing the amount of radioactivity in the extracted tube. 
Samples are typically analyzed in duplicate at a given 
volume and a correction factor is used to convert the 
mass measured within a given assay tube to a concen-
tration (mass per unit volume of serum or plasma). 
The average intra (within)-assay coefficient of variation 
(variation among duplicate samples measured in the 
same assay) as well as inter (between)-assay coefficient 
of variation (variation among duplicate samples mea-
sured in different assays) should be reported. If possible, 
assay results should be compared with other existing 
tests. A final test involves demonstrating that the assay 
measurements are consistent with known physiological 
events. For example, an assay for bovine LH should 
detect relatively low and high concentrations of LH, 
respectively, before and after an injection of GnRH in 
cattle.
The procedures for assaying hormones in serum or 
plasma have evolved over time. An important change 
over the last 2 decades has been the commercializa-
tion of assay kits for the measurement of hormones 
and metabolites. The new kits (typically in an ELISA 
format) are convenient and may require less time for 
assay completion compared with traditional RIA. Un-
fortunately, a commercially available kit may have not 
been validated for the target species or the biological 
fluid (serum, plasma, or otherwise) that is used in the 
assay. When ELISA is used to measure a hormone, 
then there should be a minimum expectation for assay 
validation. This minimum expectation should include 
the specificity of the primary antibody, a description 
of the standard curve in terms of the mass of hormone 
at each point, the sensitivity of the assay, parallelism 
or linearity of diluted samples, percent recovery of the 
added mass, the intra- and interassay CV, and com-
parison with existing RIA or ELISA or a demonstration 
of hormone changes during known physiological events.
Statistical Methods and Data Analysis  
(Table 1, Item 10)
The methods recommended for analysis of some 
common reproductive measures are outlined in Table 
2, which provides details of outcomes, unit of analysis, 
inclusion criteria, and suggested methods of analy-
sis; information for further outcome measures are in 
Supplemental Table S1 (http://dx.doi.org/10.3168/
jds.2015-9445). The principles behind these recom-
mendations are fundamental to the nature of the data 
being analyzed. New statistical techniques may even-
tually improve on those recommended here, but these 
represent the most correct currently available methods 
of analysis of reproductive data. Errors in analysis in-
clude evaluation of dichotomous outcomes as if they 
were continuous and normally distributed (i.e., using 
linear regression). Failure to use a correct technique 
for the distribution of the outcome (e.g., pregnant to 
an insemination; yes or no) will, at least, typically un-
derestimate variance, leading to incorrect application 
of statistical approaches and increased possibility of 
type I error. For dichotomous outcomes, logistic regres-
sion is a correct method and produces an odds ratio. 
When the outcome is common (experienced by >10 
to 20% of study units (e.g., probability of pregnancy 
per insemination), the odds ratio will be more extreme 
than the risk ratio. Application of Poisson regression to 
estimate the risk ratio may be preferable and produces 
effect estimates that are more intuitively expressed and 
understood (Barros and Hirakata, 2003; Ospina et al., 
2012; O’Connor, 2013).
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When the outcome is the interval to an event (in-
semination, pregnancy, pregnancy loss, or culling), the 
correct method is time-to-event (survival) analysis (Lee 
et al., 1989). A common error is to use linear regression 
to assess the mean time to an event, including only 
those cows that experience that event. This introduces 
a potentially substantial bias by excluding all cows that 
failed to achieve the endpoint of interest (i.e., ignoring 
all cows that did not become pregnant despite being 
eligible and under study for weeks or months), and by 
having incorrect variance for the data that are ana-
lyzed.
When herd-level analysis is undertaken, the distribu-
tion of binary cow- or lactation-level variables aggre-
gated to the herd level may be treated as continuous 
data. Although one cow is either pregnant or not, the 
annual 21-d pregnancy rates for many herds might 
range from 30 to 50%, with essentially all values be-
tween the represented range (or at least possible). In 
cases of such herd-level data, linear regression may be 
adequate; this can enhance communication of results 
but some caution is required. The underlying binomial 
distribution is heteroscedastic, although this is less 
pronounced if all observed percentages are between, for 
example, 30 and 70%, and fitted values can be outside 
0 to 100%. Testing that residuals are normally distrib-
uted and that all predicted values lie between 0 and 
100%, and undertaking transformations for analysis if 
necessary, are important.
Statistical methods must account for any clustering 
of the outcome variable, because assumptions of sta-
tistical independence of observations often do not hold 
(e.g., cows within a pen or herd). Clustering can occur 
when the analysis includes multiple inseminations (or 
other observations) from the same lactation, multiple 
lactations from the same cow, or multiple cows from 
the same herd. The effect of farm or pen needs to be 
considered in multi-site studies or when multiple pens 
within a site are used. The clustering effects should be 
accounted for using either fixed effects or, more often, 
random effect models (McDermott and Schukken, 1994; 
Schukken et al., 2003). References on study design that 
examine the unit of analysis and discuss the impor-
tance of clustering in general (Dohoo et al., 2003) and 
in cattle studies (St-Pierre, 2007; Tempelman, 2009) 
are available.
It is strongly recommended that investigators seek 
statistical advice in both the design and analysis phase 
of the study to ensure that appropriate designs, sample 
sizes, and statistical analyses are used. The statistical 
methods applied to each analysis should be described 
and, critically, the unit of analysis should be stated. 
When a reference group is used, the reference group 
must be clearly stated for each variable analyzed.
Censoring
For time-to-event variables (e.g., time to pregnancy), 
reasons and times of right censoring must be stated, and 
numbers of study units for each reason reported. Right 
censoring results when cattle die or are otherwise lost 
from a study before the end of the study period (e.g., 
culled before pregnancy status is determined). When 
modest numbers of lactations are right censored, the 
sensitivity of effect estimates to the 2 extreme devia-
tions from independent censoring assumptions should 
be assessed and reported. These extreme deviations are 
(1) that all censored records experienced the event at 
the time they were censored, and (2) that no censored 
records would have experienced the event in a long pe-
riod had they not been censored.
Example: Survival Analysis. 
“For the analysis of time to pregnancy, cows that 
were not diagnosed pregnant were considered right 
censored. A right censored observation meant that 
pregnancy had not occurred by the end of study 
or by the time observation of the subject had 
ceased. Overall, 42 of the total of 212 cows were 
censored for time to pregnancy. Similarly, if the 
first ovulation was not observed by 80 DIM, the 
observation was right censored; 8 of the 76 cows 
[from Bernal-Santos et al. (2003) and Castaneda-
Gutierrez et al. (2005)] were censored (de Veth et 
al., 2009).”
For each result presented, the number of observations 
used in the analysis should be reported and discrepan-
cies among outcomes and between planned and actual 
numbers explained; for example, due to omission or 
inability of collection of a sample or based on exclu-
sion of a study unit (including the reason for exclu-
sion). The numbers included in the analysis should be 
described as being based on intention-to-treat or on 
final inclusion criteria. Normally, the intention-to-treat 
basis should be included. For example, this would mean 
providing results for all animals enrolled in the study, 
and not exclusively for those that, for example, were 
detected in estrus or were retrospectively determined to 
be cyclic or to have been successfully synchronized by 
the treatment. The latter subgroup analyses are legiti-
mate for exploring hypotheses and probing the nature 
of responses to treatment but should not be the only 
analyses reported. Specifically, the numbers and pro-
portions of animals initially eligible but not enrolled or 
enrolled but not included in each final analysis should 
be reported explicitly by treatment group, along with 
reasons for these exclusions.
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For the primary outcomes and each secondary 
outcome, at least crude descriptive statistics of the 
absolute performance and measures of variance (e.g., 
mean and SD or median and interquartile range) must 
be reported. The process, methods, and cut-points for 
screening of covariates to be assessed in multivariable 
models and for checking collinearity among predictors 
must be described. This should include details of the 
procedure (e.g., “the association of each binary covari-
ate with the outcome was assessed in a 2 × 2 contingen-
cy table using the Chi-square statistic, and those with 
P < 0.2 were offered to the multivariable model,” and 
“correlation among continuous covariates was assessed 
with Pearson correlation coefficients and if r > |0.8|, 
the more biologically plausible variable was retained 
and the other not analyzed further.” Statements such 
as “variables were screened with SAS” are insufficient 
to provide an understanding of the approach used in the 
analyses. It is not necessarily advantageous or prudent 
to test all possible interactions, but in a randomized 
trial, at least interactions between treatment and sig-
nificant covariates in the final model, or those putative 
interactions with treatment expected and accounted for 
in the study design should be tested in the statistical 
model. It may be helpful to describe the statistical “ma-
terials” (e.g., Proc Mixed in SAS) but it is necessary 
to report the method (e.g., “mixed linear regression, 
including a random effect of herd and accounting for 
repeated measures of plasma progesterone”). The struc-
ture of accounting for correlation of outcomes (repeated 
measures or clustering) and the means by which the 
structure was chosen should be described [e.g., “the 
correlation structure that produced the lowest Akaike 
information criterion for the final model was selected 
such that repeated measures of the outcome were ac-
counted for with an autoregressive (type 1) correlation 
structure, while the clustering of cows within herds 
was accounted for with a compound symmetry struc-
ture”]. The method of model building (e.g., manual or 
automated; forward selection or step-wise; backward 
elimination or step-wise) must be specifically described 
(as these terms are used with varying meanings), and 
steps taken to identify confounding effects should be 
specified. The effect measures must include a measure 
of variance (standard error of differences, confidence in-
terval, or standard errors of means). If treatment effects 
or results in each group are reported as least squares 
means, the covariates accounted for in the least squares 
means must be clearly specified. There are mixed views 
about fitting baseline covariates (i.e., measures from 
each subject taken before treatments are first adminis-
tered) in statistical models from randomized controlled 
trials. Models with no such covariates fitted should be 
reported along with any other models.
Results: Flow of Study Units  
(Table 1, Items 17 and 18)
It is almost inevitable that cattle will be lost to death 
or removal or lost to follow-up during studies, and a 
critical part of understanding the rigor with which a 
study is conducted is to understand how many subjects 
were lost, the causes of loss, and the timing of that loss. 
A table or figure outlining these losses by group is ideal 
for addressing this requirement (Sargeant et al., 2010).
Deviations to the study protocol and the number 
of animals to which this applied should be listed and 
reasons for these should be detailed. Similarly, if there 
are no deviations to protocol, this should also be noted 
(Sargeant et al., 2010).
Baseline Demographics (Table 1, Item 15)
A brief statement or table outlining the demograph-
ics of each treatment group provides essential informa-
tion contributing to the understanding of a study. The 
information should be reported to ensure that numbers 
of study units are easily identified, that information 
for each relevant level of the organizational structure is 
present, and that the form of presentation provides an 
opportunity for further analysis (Sargeant et al., 2010). 
Reproductive studies will be influenced by many fac-
tors, including the age, parity, weight, milk production, 
and nutritional status of the cattle involved. At the 
herd level, weather, nutrition, stocking density, type of 
housing, or pasture system could influence responses. 
Consequently, baseline information on these should be 
provided.
When studies are used as data in subsequent studies 
(e.g., meta-analysis), herd- or study-level descriptions 
of the environment and nutrition of the group may 
help to explain the heterogeneity of variance observed 
among studies. Substantial heterogeneity has been 
observed in studies examining the effects of hormonal 
interventions designed to increase conception at a syn-
chronized estrus. Consequently, we provide suggestions 
for providing information on the cows, environment, 
and nutrition (Supplemental Table S2; http://dx.doi.
org/10.3168/jds.2015-9445).
Baseline Data: Environment and Nutrition  
(Table 1, Item 15)
Guidelines to environmental descriptions are provided 
in Supplemental Table S2 (http://dx.doi.org/10.3168/
jds.2015-9445). These guidelines are not in themselves 
part of the reporting guideline checklist but elaborate 
on the general requirement to describe the environmen-
tal, management, and nutritional context of the study. 
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These recommendations are modified from those devel-
oped by Lean and Lean (2010) and are based on the 
information required for the CPMDairy model (CPM-
Dairy, version 3.08; http://cahpwww.vet.upenn.edu/
node/77). The extent to which conditions are described 
will depend on the nature of the hypotheses. Studies 
that have extended periods during which reproductive 
outcomes may be influenced or that involve multiple 
commercial herds and do not have a primary focus on 
effects or interactions of nutrition or the physical envi-
ronment (weather or housing) may provide less detail 
on nutritional management or weather conditions. It is 
important to report in detail the assays used to make 
determinations of feed value as the assay methods can 
vary among laboratories used for testing. We recom-
mend testing of individual feed components rather than 
total mixed rations, although testing pooled samples 
of these obtained directly from mixer feed-out can be 
useful.
The challenges outlined above for the execution of 
nutritional intervention studies (in particular, the diffi-
culty of inevitable confounding for larger interventions 
resulting from the additions of lipids, proteins, or carbo-
hydrates) require that descriptions of diets be detailed. 
In particular, the intervention under study should be 
fully described. If a fat is the intervention studied, detail 
on the fatty acid profile and level of ruminal protection, 
if present, should be provided. Similarly, protein-based 
interventions should have amino acid profiles provided. 
Descriptions such as “used according to manufacturer’s 
recommendations” or stating the composition according 
to the guaranteed analysis is not enough—guaranteed 
analyses are usually stated as minimum or maximum 
guarantees and may not adequately reflect the nutri-
ents that a supplement provides. Confounding arises if 
the addition of one ingredient to a ration results in an 
incremental increase in DMI or, if DMI is decreased or 
static to controls, the loss of intake of another nutrient 
or nutrients. Attention must be paid to changes in diet 
over time.
Pasture feeding poses particular challenges to ensur-
ing that the description of environmental conditions is 
adequate, especially for nutritional inputs. Estimations 
of pasture mass can be made using physical cuts of 
pasture, electronic density measures, plate meters, or 
geospatial methods. Alkanes and other markers can be 
used to estimate individual intakes of cattle. However, 
the precision of these methods is very variable; there-
fore, the precision with which dry matter estimation is 
made is low compared with daily measures in confined 
systems, and not frequently made at the level of the 
individual. Similarly, pasture varies in composition 
seasonally and during a day and careful thought needs 
to be given to the type of study attempted and level 
of precision of pasture nutritive values required to sup-
port the hypotheses studied. Care should be taken to 
ensure that pasture studies are not pseudo-replicated. 
Specifically, care should be taken to ensure that there 
are replicated groups of cattle grazing on pasture and 
not simply two herds, even if these have randomly as-
signed pastures. A good example of a replicated study 
design for cattle on pasture is provided by Auldist et 
al. (2013). Cattle on pastures are exposed to internal 
and external parasite loads or challenge; a description 
of parasite status, and possibly treatment to remove 
these, before or during the trial may be needed.
Baseline Data: Disease (Table 1, Item 15)
The periparturient period has the highest incidence 
of disease for adult cattle. We provide clear and re-
producible descriptions of disease (Supplemental Table 
S3; http://dx.doi.org/10.3168/jds.2015-9445), whether 
recorded as an outcome or a covariate. In cases of 
metabolic disease, the comments of Lean et al. (2009) 
concerning definitions of these disorders are useful in 
providing a series of postulates by which the suitabil-
ity of metabolic disease definitions can be assessed. In 
some of the cases of disease outlined in Supplemental 
Table S3 (http://dx.doi.org/10.3168/jds.2015-9445), 
the postulates provided by Lean et al. (2009) have not 
been met; however, the definitions represent the best 
available evidence.
Adverse Effects (Table 1, Item 19)
Adverse or side effects including injury, disease, or 
death that could be reasonably associated with treat-
ment must be reported and the absence of these should 
be stated. These may include apparently direct (e.g., 
hypersensitivity reaction to an injected treatment) or 
indirect (abscess at an injection site or physical injury 
in the course of treatment administration) effects of 
treatment.
Discussion and Interpretation (Table 1, Item 20)
The study’s novelty, strengths, benefits, limitations, 
weaknesses, and harms should be explicitly described 
and discussed both relative to the hypothesis and to 
other published work. There should be a critical as-
sessment of whether the objectives of the study were 
met, and what the implications of the results are, both 
for application in the field and for future investigation. 
Rather than a methodical review of each experiment 
or result, the discussion should include a synthesis of 
the methods and results to address the points above. 
Thoughtful critique of what could have been done differ-
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ently or better, or why hypotheses were not supported, 
may strengthen rather than diminish the utility of a 
paper, assuming there were no fatal flaws in the design 
or execution of the work. Readers are more interested 
in the collated points and insights raised, rather than 
whether this was the first report of a specific finding.
In particular, despite randomization, possible 
confounders (unmeasured variables related to both 
treatment and the outcome) should be discussed. For 
example, the implications of hormonal treatments that 
produce sexually active groups should be considered 
when treated cattle are mixed with controls, as this 
might bias the treatment effect toward the null by indi-
rectly increasing estrus expression in the control group.
Validity and Generalizability (Table 1, Item 21)
The concepts of external and internal study validity 
are central to the discussion and interpretation of data. 
The greatest internal validity of an observation results 
when experimental conditions are tightly controlled 
(e.g., under laboratory conditions) and there is little bias 
or measurement error. However, responses observed in 
tightly controlled studies may not reflect the response 
or variability of responses that can be expected in the 
field with more uncontrolled or unmeasured covariates. 
In other words, the laboratory study may have a low 
external validity. The study designs with the greatest 
external validity are randomized controlled clinical tri-
als, especially multicenter studies, and meta-analytical 
studies derived from these. Sargeant et al. (2010) noted 
that a randomized trial conducted at a single site may 
not be representative of the variety of clinical situa-
tions possible, and authors should acknowledge this. 
The discussion should explicitly include comments on 
the implications of the study design, subjects, and envi-
ronmental context on the generalizability of the results 
(i.e., the external validity or the extent to which the 
results and inferences can be extrapolated and applied 
beyond the study animals and site).
Many of the guideline sections above reflect the need 
to achieve excellent internal validity of a study. For 
example, the section on assays outlines the methods 
required to ensure that hormonal measures undertaken 
are both accurate and precise. If these are well con-
ducted and documented, the internal validity of such 
measures should be good, leading to confidence in 
the results. The external validity of a study, however, 
reflects the extent to which a study can be applied be-
yond the population in which it was conducted. The 
target population for a study must be considered and 
inferential errors can result from studies that fail to 
sufficiently consider the context in which a study was 
conducted, or extend the relevance beyond the popula-
tion in which the study was conducted. An example 
might be to conclude that the results achieved by use 
of an intervention in maiden heifers would be applicable 
to lactating cow populations.
The atomistic and ecological fallacies should be 
considered in study design and in interpretation and 
discussion of results. The atomistic fallacy occurs when 
a relationship observed at a lower level is incorrectly as-
sumed to occur also at a higher level (Diez-Roux, 1998; 
Diez Roux, 2002). The ecological fallacy occurs when 
a relationship observed at a higher level is incorrectly 
assumed to occur also at a lower level (Diez-Roux, 
1998; Diez Roux, 2002). These fallacies can occur only 
when a relationship at one level differs from the cor-
responding relationship at a higher (or lower) level. 
For example, higher-producing herds may have overall 
better reproductive performance, but within herds, 
the higher-producing cows may or may not have worse 
reproductive performance (Bello et al., 2012). A treat-
ment that increases the probability of pregnancy to first 
insemination may be associated with a difference in the 
interval to AI. Consequently, pregnancy at the group 
level may not be altered. If, for example, the treatment 
reduces probability of detecting estrus, or reduces the 
probability of pregnancy at subsequent inseminations, 
or delays the next ovulation in nonpregnant cows, then 
pregnancy at the group level may be reduced.
General Interpretation of Results (Table 1, Item 22)
The general interpretation of results should allow 
the reader to understand the significance of the work 
conducted in the context of the effects on industry and 
society in general. The work should be discussed with 
regard to existing or similar studies; if similar studies 
do not exist, authors should indicate the limitation that 
this represents to broader interpretation (Sargeant et 
al., 2010).
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CONCLUSIONS
With developments in laboratory analyses, statistical 
methods, and the increased scale of animal agriculture 
internationally, research on animal reproduction needs 
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to evolve. It is our hope that the checklist detailed here 
can contribute to improving the quality of reporting, 
reproducibility, and applicability of research findings. 
Furthermore, more consistent reporting of experi-
mental conditions can reduce barriers to the conduct 
of comprehensive meta-analyses, which will help the 
research community explore the most complex interac-
tions influencing reproduction.
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